Homira Behbahani

Dr. Homira Behbahani


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2002 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
JAJan Andersson
Jan Andersson
SKSabine Kinloch
Sabine Kinloch
ASAnders Sönnerborg
Anders Sönnerborg
JNJakob Nilsson
Jakob Nilsson
TFThomas E. Fehniger
Thomas E. Fehniger
LPLuc Perrin
Luc Perrin
Human immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte (CTL) responses are detectable shortly after the acute phase of HIV infection, but they cannot control viral replication and prevent development of chronic immune suppression. This article describes a defect in the coexpression of perforin in granzyme A-positive CD8+ T cells in lymphoid tissue from patients with acute HIV infection and a reduction in the perforin-dependent nuclear translocation of granzyme A. Furthermore, intracellular levels of HIV DNA and RNA found in lymphoid tissue were higher (10–100 times) than those found in blood, and blood samples showed more-coordinated cellular perforin/granzyme A expression. This suggests that mechanisms inhibiting CTL-mediated cytotoxicity are operative in lymphoid tissue early in the course of HIV infection.

1 August 2006 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
HBHomira Behbahani
Homira Behbahani
ISIrina G. Shabalina
Irina G. Shabalina
BWBirgitta Wiehager
Birgitta Wiehager
HCHérnan Concha
Hérnan Concha
KHKjell Hultenby
Kjell Hultenby
MAMaria Ankarcrona
Maria Ankarcrona

1 November 2010 in Neurochemistry International
Verified
Journal Article
Closed access
HBHomira Behbahani
Homira Behbahani
PPPavel F. Pavlov
Pavel F. Pavlov
BWBirgitta Wiehager
Birgitta Wiehager
TNTakeshi Nishimura
Takeshi Nishimura
BWBengt Winblad
Bengt Winblad
MAMaria Ankarcrona
Maria Ankarcrona

25 October 2018 in Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
TDTaher Darreh-Shori
Taher Darreh-Shori
SRSareh Rezaeianyazdi
Sareh Rezaeianyazdi
ELErica Lana
Erica Lana
SMSumonto Mitra
Sumonto Mitra
AGAnna Gellerbring
Anna Gellerbring
HBHomira Behbahani
Homira Behbahani
OMI/HTRA2 (high-temperature requirement serine protease A2) is a mitochondrial serine protease involved in several cellular processes, including autophagy, chaperone activity, and apoptosis. Few studies on the role of OMI/HTRA2 in Alzheimer’s disease (AD) are available, but none on its relationship with the cholinergic system and neurotrophic factors as well as other AD-related proteins. In this study, immunohistochemical analyses revealed that AD patients had a higher cytosolic distribution of OMI/HTRA2 protein compared to controls. Quantitative analyses on brain extracts indicated a significant increase in the active form of OMI/HTRA2 in the AD brain. Activated OMI/HTRA2 protein positively correlated with stress-associated read-through acetylcholinesterase activity. In addition, α7 nicotinic acetylcholine receptor gene expression, a receptor also known to be localized on the outer membrane of mitochondria, showed a strong correlation with OMI/HTRA2 gene expression in three different brain regions. Interestingly, the activated OMI/HTRA2 levels also correlated with the activity of the acetylcholine-biosynthesizing enzyme, choline acetyltransferase (ChAT); with levels of the neurotrophic factors, NGF and BDNF; with levels of the soluble fragments of amyloid precursor protein (APP); and with gene expression of the microtubule-associated protein tau in the examined brain regions. Overall, the results demonstrate increased levels of the mitochondrial serine protease OMI/HTRA2, and a coherent pattern of association between the activated form of OMI/HTRA2 and several key proteins involved in AD pathology. In this paper, we propose a new hypothetical model to highlight the importance and needs of further investigation on the role of OMI/HTRA2 in the mitochondrial function and AD.

26 October 2015 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
ARAnnica Rönnbäck
Annica Rönnbäck
PPPavel. F. Pavlov
Pavel. F. Pavlov
MMMansorah Mansory
Mansorah Mansory
PGPrisca Gonze
Prisca Gonze
NMNicolas Marlière
Nicolas Marlière
HBHomira Behbahani
Homira Behbahani
Accumulation of amyloid β‐peptide (Aβ) in the brain is an important event in the pathogenesis of Alzheimer disease. We have used a transgenic mouse model expressing human amyloid precursor protein (APP) with the Arctic mutation to investigate whether Aβ deposition is correlated with mitochondrial functions in these animals. We found evidence of mitochondrial dysfunction (i.e., decreased mitochondrial membrane potential, increased production of reactive oxygen species and oxidative DNA damage) at 6 months of age, when the mice showed very mild Aβ deposition. More pronounced mitochondrial abnormalities were present in 24‐month‐old TgAPParc mice with more extensive Aβ pathology. This study demonstrates for the first time mitochondrial dysfunction in transgenic mice with a mutation within the Aβ peptide (the Arctic APP mutation), and confirms previous studies suggesting that mitochondrial dysfunction and oxidative stress is an early event in the pathogenesis of Alzheimer disease. This study demonstrates mitochondrial dysfunction in transgenic mice with a mutation within the amyloid beta (Aβ) peptide (the Arctic amyloid precursor protein (APP) mutation). We found evidence of mitochondrial dysfunction (i.e. decreased mitochondrial membrane potential (MMP), increased production of reactive oxygen species (ROS) and oxidative DNA damage) at 6 months of age, when very mild Aβ deposition is present in the mice. Also, the cytochrome c (COX) activity was significantly decreased in mitochondria from transgenic mice at 24 months of age.

1 May 2007 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
HBHomira Behbahani
Homira Behbahani
LWLilian Walther-Jallow
Lilian Walther-Jallow
EKElin Klareskog
Elin Klareskog
LBLinda Baum
Linda Baum
AFAudrey L French
Audrey L French
JAJan Andersson
Jan Andersson
Suppression of immune activation and increased inflammation are prevalent during viral infection. To investigate the role of inflammation in HIV transmission, we studied the infectious and inflammatory milieu in cervical mucosa from HIV-1- and human papillomavirus (HPV)-coinfected and HPV-monoinfected women. The numbers of cytokine-, chemokine-, and p24-expressing cells were determined using in situ imaging analysis and intracellular staining of p24 antigen. Significantly higher expression of the proinflammatory cytokines, interleukin (IL)-1α/β, was seen in cervical tissue from HIV/HPV-coinfected as compared with HPV-monoinfected tissues, whereas IL-2- and interferon (IFN)-γ-expressing cells were higher in HPV-monoinfected tissues. IL-10 was low in both groups, whereas IL-4 was significantly higher in HPV-monoinfected and HIV/HPV-coinfected tissues than in HIV/HPV-negative controls. RANTES and macrophage inflammatory protein (MIP)-1β but not MIP-1α were significantly higher in the genital tract of HIV/HPV-coinfected as compared with HPV-monoinfected individuals and controls. HIV/HPV-coinfected tissues had a higher level of human leukocyte antigen D-related (HLA-DR)-expressing dendritic cells (DCs). There was a positive correlation between the number of CD4+ and CD8+ T cells as well as CD1a, IL-1α, and RANTES expression and p24 antigen-expressing cells in the HIV/HPV-coinfected tissues. These findings suggest the persistence of immune activation and inflammation in the genital tract of women with HPV monoinfection and in HIV-infected women coinfected with HPV.